College of Medical Science and Technology
SINCE 2011
COLLEGE OF MEDICAL SCIENCE AND TECHNOLOGY
Departments
- School of Medical Laboratory Science and Biotechnology (Bachelor’s, In-Service Master and Master programs)
- Institute of Biotechnology in Medicine
- Graduate Institute of Biomedical Informatics (Master and Ph.D. programs)
- Master’s Program in Institute of Cancer Biology and Drug Discovery
- Ph.D. Program in Institute of Cancer Biology and Drug Discovery (joint program with Academia Sinica)
- Ph.D. Program in Medical Neuroscience (joint program with National Health Research Institutes)
- International Master Program in Medical Neuroscience
- Institute of Translational Medicine (joint program with Academia Sinica)
- International Ph.D. Program in Translational Medicine
- International Master Program in Translational Medicine
- International Center for Health Information Technology
Focus on the development of translational medicine to build a world-class translational medicine research environment.
- 1965 Established the School of Medical Laboratory Science and Biotechnology
- 1998 Established Asia’s first Graduate Institute of Biomedical Informatics
- 2010 Established the Preparatory Office of the School of Medical Science and Technology; cooperated with the National Institutes of Health to establish the Ph.D. Program in Medical Neuroscience; cooperated with the Academia Sinica to jointly set up the Ph.D. Program in Institute of Cancer Biology and Drug Discovery and Institute of Translational Medicine
- 2011Established College of Medical Science and Technology
- 2014 the Graduate Institute of Biomedical Informatics was the first department in Asia to receive International Medical Informatics Association accreditation in both Master and Ph.D. programs
- 2015 Established the Ph.D. Program for Medical Biotechnology and launched International Center for Health Information Technology
- 2016-2019 Cooperated with the Massachusetts Institute of Technology (MIT) to co-host the TMUxMIT Hackathon
- 2017 Professor Yu-Chuan (Jack) Li was elected as the first Taiwanese academician in the American College of Medical Informatics
- 2017 Established the Graduate Institute of Cancer Biology and Drug Discovery
- 2019 Professor Yu-Chuan (Jack) Li and Shiow-Lin Pan received National Innovator Award
- 2020 Professor Jian-Ying Chuang received the MOST Grant for the Columbus Program
- 2020 Established the International Ph.D. Program for Translational Science
- 2021 Professor Yu-Chuan (Jack) Li received the 7th National Industrial Innovation Award from the Ministry of Economic Affairs
- 2021 Professor Shiow-Lin Pan and Associate Professor Wei-Chun HuangFu received Future Tech Awards
- 2022 Ph.D. Program for Neuro-regenerative Medicine was renamed Ph.D. Program in Medicine Neuroscience
- 2022 Established the International Master Program in Medicine Neuroscience Science
- 2021-2023 Professor Yu-Chuan (Jack) Li was elected as the President of International Medical Informatics Association (IMIA)
- 2023 Joined the "Program on Bilingual Education for Students in College" (BEST) by the Ministry of Education.
- 2024 Professor Shiow-Lin Pan and her research team was honored with the Boehringer Ingelheim "Unicorn 2.0" Biomedical Startup Award.
The College of Medical Science and Technology (CoMST) currently consists of one undergraduate department, two graduate institutes, two master's degree program, and five doctoral degree programs. It encompasses five major areas of specialization: Medical Science and Biotechnology, Biomedical Informatics, Cancer Biology and Drug Discovery, Neuroscience, and Translational Medicine.
The CoMST was established in 2010, building upon the foundation of the School's Department of Medical Laboratory Science and Biotechnology and the Institute of Biomedical Informatics in medical applications. Starting in 2010, it collaborated with two major academic research institutions in Taiwan, the National Health Research Institutes (NHRI) and the Academia Sinica, to offer three doctoral degree programs: "Cancer Molecular Biology and Drug Discovery," "Medicine Neuroscience," and "Translational Medicine." Additionally, in 2015, 2017, 2020, and 2022, the college established the "Ph.D. Program in Medical Biotechnology," "Graduate Institute of Cancer Biology and Drug Discovery (Master)," "International Ph.D. Program for Translational Science," and "International Master Program in Medicine Neuroscience," respectively. In February 2023, the college will integrate its five major areas of specialization and degree programs into the Shuang-Ho campus, establishing close connections with Shuang-Ho Hospital and the international Biodesign program to construct an international Shuang-Ho Park jointly, cultivating biomedical talents with a global perspective and creating a benchmark institution with international influence and competitiveness.
The School of Medical Laboratory Science and Biotechnology, established in 1965, has cultivated thousands of outstanding alumni with great performance in industry, government, academia and research fields. The school provides diverse and solid experimental medicine-related courses and practical training. It focuses on cultivating clinical laboratory talents, supplemented by biotechnology industry R&D personnel and medical researchers. In 2015, the newly established doctoral program in medical biotechnology brought life science research into a new era.
The Graduate Institute of Biomedical Informatics, the first biomedical informatics graduate institute in Asia. In 2015, the institute signed a memorandum of cooperation with Singaporean companies-PULSESYNC and CADI SCIENTIFIC, and started a summer internship program with the two companies in 2016, and also signed with DSFederal Inc. for summer internship in USA. Clinical informatics uses theories and methods of information technology to support patient care and improve patient-care quality. The research scope of basic medical informatics includes biomedical database, data analysis and exploration, as well as genetic database of diseases, etc. The goal is to develop biomedical imaging and signal processing technology, as well as the integration of information technology and public health, with translational medicine being the direction of future research.
Ph.D. Program for Cancer Molecular Biology and Drug Discovery, driven by the need for clinical medicine, focuses on the development of new cancer drugs and explores fast and effective ways in the early diagnosis and treatment of cancer. In 2017, the school established the Graduate Institute of Cancer Biology and Drug Discovery by combining the existing doctoral programs in cancer biology and drug discovery, thus making its education system more complete with the master’s programs. As a result, students are able to establish a solid foundation from the beginning and acquire professional knowledge in cancer biology and drug research and development.
Ph.D. Program in Medical Neuroscience mainly explores the physiological and pathological mechanisms of severe central nervous system injuries and neurodegenerative diseases. The goal is to develop effective drugs or strategies to treat or improve related diseases. In 2022, the college launched the International Master Program in Medical Neuroscience to establish a comprehensive education system that integrates with the Ph.D. Program in Medical Neuroscience, enabling students to learn from the fundamentals and build a solid foundation. The program accepts international students.
The Ph.D. Program for Translational Medicine has established a comprehensive research and educational system in order to cultivate cross-field research talents in translational medicine. In 2020 and 2022, the International Ph.D. Program and Master Program in Translational Medicine were established with the aim of nurturing talented researchers in this field and promoting educational exchanges between the university and foreign educational institutions. Through two-way communication with international graduate students from various countries, the program has gained a better understanding of research topics that meet international needs.